The massive robot-making, pacemaker-inventing medtech company Medtronic is facing a financial snag: the humble stapler.

CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by ...

Andrew Chung, MD, performed the first biportal endoscopic spinal fusion with Medtronic's Mazor robot, according to a Feb. 17 news release.

Discover why Medtronic's growth in robotics, AI, & solid fundamentals make it a Buy ahead of earnings. Read my analysis here.

Bogle, Medtronic’s head of medical affairs for digital surgery, also discussed the company’s plans to train surgeons for its ...

Hospitals and practices have bolstered their surgical offerings with spine and orthopedic robots in January. Note: This is not an exhaustive list. 1. Jonesboro, Ark.-based NEA Baptist added the Mako ...

ForSight Robotics announced today that it appointed Dr. Fred Moll, founder of surgical robot giant Intuitive, to its board of ...

5 analysts have expressed a variety of opinions on Medtronic MDT over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments ...

Shares of Medtronic are benefiting from an improved earnings growth outlook. The company is capturing strong demand for its new lineup of high-tech medical devices. The stock trades at just 16 ...

In this article, we are going to take a look at where Medtronic plc (NYSE ... “We’re going to use, essentially, the robots to be a member of the healthcare team in the healthcare spaces ...

considering the benefits of the minimally invasive surgeries that robot systems allow physicians to perform. Beyond that, Medtronic should benefit from important long-term trends, including an ...